Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Mediwound ( (MDWD) ).
On January 15, 2026, MediWound Ltd. filed materials for an extraordinary general meeting of shareholders scheduled for February 19, 2026 in New York, at which investors will be asked to approve an increase of 300,000 ordinary shares reserved for issuance under the company’s 2024 Share Incentive Plan. Shareholders of record as of the close of business on January 16, 2026 are entitled to vote, and the board of directors is unanimously backing the proposal, which, if approved, would expand the pool of shares available for equity compensation and could modestly dilute existing holders while strengthening MediWound’s ability to attract and retain key personnel.
The most recent analyst rating on (MDWD) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on Mediwound stock, see the MDWD Stock Forecast page.
Spark’s Take on MDWD Stock
According to Spark, TipRanks’ AI Analyst, MDWD is a Neutral.
Mediwound’s overall stock score is primarily impacted by its challenging financial performance, characterized by ongoing losses and negative cash flows. Technical analysis indicates a bearish trend, further weighing down the score. Valuation metrics are unfavorable due to negative earnings and the absence of dividends. While the earnings call provided some positive insights into future growth potential, these are overshadowed by current financial and operational challenges.
To see Spark’s full report on MDWD stock, click here.
More about Mediwound
MediWound Ltd., headquartered in Yavne, Israel, is a foreign private issuer listed in the United States and operates in the biopharmaceutical/medical sector, with its ordinary shares traded on a foreign exchange and subject to U.S. securities regulation. The company uses equity-based compensation tools, including a 2024 Share Incentive Plan, as part of its capital and employee-incentive structure, reflecting a focus on incentivizing management and staff through share-based awards.
Average Trading Volume: 79,488
Technical Sentiment Signal: Sell
Current Market Cap: $218.5M
For an in-depth examination of MDWD stock, go to TipRanks’ Overview page.